Can-Fite Biopharma Ltd Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RHUMBLINE ADVISERS | 02/13/2026 | 281.88 K | $56.37 K | 386.57% | 1.71% |
| JANE STREET GROUP, LLC | 02/12/2026 | 205.00 K | $193.07 K | 100.00% | 1.24% |
| OSAIC HOLDINGS, INC. | 02/17/2026 | 36.00 K | $7.20 K | 100.00% | 0.22% |
| UBS GROUP AG | 01/29/2026 | 20.94 K | $4.19 K | 1,501.07% | 0.13% |
| XTX TOPCO LTD | 02/17/2026 | 18.69 K | $3.74 K | 100.00% | 0.11% |
| BOGART WEALTH, LLC | 01/30/2026 | 15.05 K | $3.01 K | 0.00% | 0.09% |
| TWO SIGMA SECURITIES, LLC | 02/17/2026 | 12.09 K | $2.42 K | 13.59% | 0.07% |
| BFC PLANNING, INC. | 10/29/2026 | 5.00 K | $1.00 K | 100.00% | 0.04% |
| FIFTH THIRD BANCORP | 02/02/2026 | 3.00 K | $600 | 0.00% | 0.02% |
| WELLS FARGO & COMPANY/MN | 02/13/2026 | 2.50 K | $500 | -7.41% | 0.02% |
| COSTELLO ASSET MANAGEMENT, INC | 02/03/2026 | 1.00 K | $200 | 0.00% | 0.01% |
| ACTIVEST WEALTH MANAGEMENT | 01/30/2026 | 200 | $40 | 0.00% | 0.00% |
| EVERSOURCE WEALTH ADVISORS, LLC | 02/06/2026 | 68 | $14 | 0.00% | 0.00% |
| MORGAN STANLEY | 05/27/2026 | 33 | $7 | -99.74% | 0.00% |
| TD WATERHOUSE CANADA INC. | 01/27/2026 | 20 | $4 | 0.00% | 0.00% |
| BNP PARIBAS FINANCIAL MARKETS | 02/10/2026 | 0 | $0 | -100.00% | 0.00% |
| CAPTRUST FINANCIAL ADVISORS | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
| SABBY MANAGEMENT, LLC | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 02/03/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Can-Fite Biopharma Ltd institutional Ownership - FAQ's
During the previous two years, 1 institutional investors and hedge funds held shares of Can-Fite Biopharma Ltd. The most heavily invested institutionals were:
American Portfolios Advisors: 1,100
5.28% of Can-Fite Biopharma Ltd stock is owned by institutional investors.
Institutional investors have bought a total of 1.10 K shares in the last 24 months. This purchase volume represents approximately $1.77 K in transactions.